Occult neurohypophyseal germinomas in patients presenting with central diabetes insipidus

1998 ◽  
Vol 5 (1) ◽  
pp. E8 ◽  
Author(s):  
Tsutomu Kato ◽  
Yutaka Sawamura ◽  
Mitsuhiro Tada ◽  
Jun-ichi Murata ◽  
Hiroshi Abe ◽  
...  

Although neurohypophyseal germinoma is known be a common initial symptom in cases of diabetes insipidus (DI), its radiological detection may take months or years even by a high-resolution magnetic resonance (MR) imaging. The term “occult neurohypophyseal germinoma” denotes such cases, but its clinical picture remains obscure. Of seven patients with neurohypophyseal germinoma presenting with DI during the last 5 years, three patients showed no evidence of tumor at the onset of DI and were treated as “idiopathic” DI. Neurohypophyseal germinoma was eventually diagnosed in these three patients as the tumor became evident on sequential MR imaging studies and the patients were successfully treated with chemotherapy and radiation therapy. To delineate the clinical features of the occult neurohypophyseal germinoma, the authors analyzed endocrinological aspects and MR images in these patients and compared them with those in two patients with true idiopathic DI and four patients with overt neurohypophyseal germinoma and DI. Nine previously reported cases in the literature were reviewed. During the stage at which the germinoma gave no notable change on MR images, patients often displayed anterior pituitary dysfunction, particularly growth hormone (GH) deficiency, or an elevation of serum or cerebrospinal fluid human chorionic gonadotropin-beta. Preceding the appearance of an obvious tumor mass, a slight swelling of the pituitary stalk with loss of normal hyperintensity of the posterior pituitary lobe was a common finding on MR imaging. Central DI associated either with an enlarged stalk, decreased GH secretion, or an elevated serum human chorionic gonadotropin-beta should prompt the diagnosis of an occult germinoma.

2010 ◽  
Vol 56 (5) ◽  
pp. 863-864 ◽  
Author(s):  
Soumen Khatua ◽  
Andrew Phillips ◽  
Jason Fangusaro ◽  
Sally Bovan ◽  
Girish Dhall ◽  
...  

1996 ◽  
Vol 31 (1-2) ◽  
pp. 21-36 ◽  
Author(s):  
Alison M. Jackson ◽  
Thomas Klonisch ◽  
Adrian J. Lapthorn ◽  
Peter Berger ◽  
Neil W. Isaacs ◽  
...  

2015 ◽  
Vol 444 ◽  
pp. 92-100 ◽  
Author(s):  
L. Aldaz-Carroll ◽  
S. Richon ◽  
V. Dangles-Marie ◽  
M. Cocquebert ◽  
T. Fournier ◽  
...  

1998 ◽  
Vol 5 (1) ◽  
pp. E6 ◽  
Author(s):  
Paul B. Rogers ◽  
Eliot C. Sims ◽  
Nicholas Plowman

Levels of human chorionic gonadotropin-beta (HCG-beta) are elevated in up to 43% of patients with intracranial germ cell tumors (GCTs) and are useful in the diagnosis of these tumors and the follow up of such patients. The ratio of blood HCG-beta to lumbar cerebrospinal fluid (CSF) HCG-beta in these patients at presentation has not been defined. Twenty-two patients with intracranial GCTs have been treated at St. Bartholomew's Hospital over the past 15 years. Two (17%) of 12 germinomas and seven (70%) of 10 nongerminomatous GCTs had elevated blood HCG-beta at presentation. Four cases of pineal region GCTs (one of 12 germinomas and three of 10 nongerminomatous GCTs) had paired, elevated, blood and lumbar CSF HCG-beta levels. The mean blood to CSF ratio was 1:10 (range 1.7-18.4), which is substantially lower than the ratio of 286:1 reported in systemic GCTs. The authors confirm the finding of a previous single report showing that ventricular CSF HCG-beta sampling via an accessible ventriculoperitoneal shunt reservoir may give a spuriously negative result, and they discuss the pathophysiology of the blood-brain barrier in the pineal region and the implications of the intrathecal administration of chemotherapy.


2016 ◽  
Vol 62 (09/2016) ◽  
Author(s):  
Xiaoyong Guan ◽  
Yifan Sun ◽  
Hongyu Zhang ◽  
Ka Liang ◽  
Kang Long ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document